Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation Redazione 12 Novembre 2020 ...
Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors Redazione 12 Novembre 2020 ...
Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors Redazione 12 Novembre 2020 ...